# Pentoxifylline Administration in Hemodialysis Patients

> **NCT03800433** · EARLY_PHASE1 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 46 (estimated)

## Conditions studied

- Anemia Renal

## Interventions

- **DRUG:** Trental 400 MG Extended Release Oral Tablet

## Key facts

- **NCT ID:** NCT03800433
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03800433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03800433, "Pentoxifylline Administration in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03800433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*